Authors
Latest:
Elevate and De-Risk Your Drug Portfolio Strategy With AIWebinar Date/Time: Wed, Aug 28, 2024 11:00 AM EDT
Latest:
Making the Grade: Registries as Sources of Regulatory-Grade RWEDr Peter Wahl, MLA, MS, Global Head of Scientific Affairs at CorEvitas, part of the PPD clinical research business of Thermo Fisher Scientific, covers key considerations for choosing registries.
Latest:
[Sponsored Content] Patient Engagement Throughout the Entire Product LifecycleIn the pharmaceutical industry, patient engagement should be centered in health education, communication, and strategy during drug discovery and throughout the product lifecycle. Cheryl Lubbert, CEO of Reverba, discusses the importance of a patient-first mindset in the industry.
Latest:
Personalizing Pharma: Overcoming Challenges to Drive Digital Customer EngagementAs HCPs continue to face time constraints and information overload, delivering relevant and personalized content becomes increasingly critical.
Latest:
HEOR: From Proving Product Value to Proving Its Own WorthThe recent shift in Health Economics and Outcomes Research functions across major pharmaceutical companies highlights a lack of understanding of its value.
Latest:
A Risk-Reward Reset: Getting Serious About Social MediaAs the digital medium poses new threats to brand equity and public safety for pharma, what can drugmakers do to better balance its essential communications benefits with the risks?
Latest:
The Real Cost of State Drug Importation Programs? Patient SafetyImporting drugs from Canada may increase the risk of US citizens being exposed to unsafe medicines.
Latest:
Maximizing China Access for Innovative TherapiesTo maximize the potential of innovative therapies in the Chinese market, it’s important to have a holistic view of the full range of options and levers, prioritize and sequence the ones with the highest impacts, and develop an integrated strategy tailored to address the country’s unmet needs.
Latest:
How to Make Your Meetings with HCPs More Insightful and SuccessfulEncounters with healthcare providers (HCPs) requires diligent preparation. Beyond understanding the value of the therapies you're offering, all touchpoints and conversations are of the highest importance - through sharing research, new ideas, and how you can support HCPs, you gain valuable, relevant insights that inform your relationship with HCPs and help them blossom.
Latest:
Evolution of Prostate Cancer Treatment Gathers SpeedAmy Butcher evaluates the current treatment options for prostate cancer and the looks to the future as clinical outcomes evolve.
Latest:
Creating Data-driven, Personalized User ExperiencesIn this video Akeel Williams, VP of Strategy and Operations, Manufacturer Solutions, explains how GoodRx uses data to continuously improve its platform for patients and providers.
Latest:
Agile, Microlearning and Engaging Training for Clinical Trial Sites: A Strategic Approach to knowledge and learning management for Biotech SponsorsBridging the gap in data utilization and knowledge/learning management is crucial for successful drug development.
Latest:
Successful Digital Transformation Depends on Quality Customer DataCompanies recognize that their success with digital starts with accurate customer data, but many struggle to manage the overwhelming volume of different data types from hundreds of sources.
Latest:
Five Steps for Automating the Pharmacovigilance ProcessHere’s how pharma businesses can speed the handling of adverse events, reduce costs, improve patient safety and spur growth through pharmacovigilance automation.
Latest:
Q&A With Daniel Lofaso, CEO of Digital ElevatorLofaso discusses strategies that biotech companies can take once its time to make the big push.
Latest:
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based ProductsAs the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
Latest:
The Future of Personalized Medicine Hinges on Pharma Executives Revolutionizing Business ModelsThe era of big pharma as product-first companies must end, as services become the larger priority.
Latest:
Beyond the Prescription: The Role Pharma Plays in Digital Health ConversationsAs social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.
Latest:
Examining Data Breaches in Pharma Companies During COVID-19Pharma companies are struggling to maintain a high level of cybersecurity amidst the pandemic.
Latest:
How Leaders Can Empower Their People to be Their BestIf you wish for your team to be diligent, innovative, and collaborative, you must first exhibit these traits yourself
Latest:
Embracing the Renaissance of Small Molecule Drug DiscoveryPharma companies may benefit from meeting challenges and embracing small molecule drug discovery.
Latest:
Strategic Commercialization of Multi-Indication Obesity Therapies: Balancing Early Access, Pricing, and Lifecycle ValueThe regulatory environment has become increasingly supportive of multi-indication development.
Latest:
Four Key Strategies for Optimizing Your Medical Congress StrategyConferences, congresses, and the digital discussions kicked off by those events create a halo effect that amplifies scientific information more so than other scientific activities.
Latest:
Beyond the Data: Making HCP Analytics Actually Work for Commercial TeamsTraditional approaches to HCP segmentation are no longer sufficient. The challenge now is to maintain personalization at scale while managing large territories and diverse customer bases.
Latest:
Operating Models for Successful DOL EngagementHow life sciences companies can design an effective operating model for DOL engagements.
Latest:
Accelerating Rare Disease Drug Development with NLP: Three Use CasesUtilizing natural language processing technologies to improve search capabilities and advance the development of therapies.
